ProCE Banner Activity

Epigenetic Therapy in Indolent B-Cell Lymphomas: A Summary Resource

Download this online resource developed to serve as a helpful guide for healthcare professionals on tazemetostat and investigational epigenetic therapies in indolent B-cell lymphomas.

Released: April 28, 2022

Expiration: April 27, 2023

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Incyte Corporation